Key statistics dashboard for Accuray Incorporated (ARAY). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Accuray Incorporated specializes in the design, development, production, and sale of advanced radiosurgery and radiation therapy equipment aimed at treating tumors. Their market footprint spans across North and South America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and the broader Asia Pacific region.
Stock Data
| Price | $0.24 |
| Market Cap | $29M |
| Enterprise Value | $171.0M |
| Beta | 1.32 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -0.59 |
| Price / Book | 0.69 |
| P/S | 0.07 |
| EV/EBITDA | -11.92 |
| EV/Sales | 0.43 |
| EV/FCF | -12.32 |
| P/FCF | -2.00 |
| Earnings Yield | -172.16% |
| FCF Yield | -50.06% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 27.73% |
| EBIT Margin | -3.57% |
| EBITDA Margin | -3.57% |
| Operating Margin | -6.58% |
| Net Margin | -12.24% |
| Return on Equity | -99.04% |
| Return on Assets | -11.09% |
| Return on Invested Capital | -10.09% |
| Return on Capital Employed | -10.48% |
Financial Health
| Current Ratio | 1.50 |
| Quick Ratio | 0.74 |
| Cash Ratio | 0.21 |
| Debt / Equity | 4.41 |
| Debt / Assets | 41.44% |
| Net Debt / EBITDA | -9.99 |
| Interest Coverage | -0.75 |
Per-Share Data
| Revenue per share | 3.28 |
| Book Value per share | 0.34 |
| Cash per share | 0.33 |
| FCF per share | -0.11 |
| Tangible Book Value per share | -0.13 |
| Dividend per share | 0.00 |
Related companies: ANIK · AVR · LNSR · MIST · MXCT · OWLT · PROF
Explore sector: Healthcare · Medical - Devices
More sections of ARAY: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks